ABOUT CSL
CSL is a leading global biotechnology company with a constantly evolving portfolio of lifesaving products, built from the company’s passion to always put patients and people first.
Headquartered in Melbourne and listed on the Australian Stock Exchange, CSL provides life-saving medicines in more than 60 countries and has over 32,000 employees worldwide. Innovation and growth is a priority for CSL, and its exceptional track record of year-on-year growth and shareholder return coupled with sustained patient impact have garnered CSL a strong reputation across its broad and diverse stakeholder base.
OUR CORE CSL BUSINESSES
CSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency.
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in U.S., Europe and China. Plasma collected at CSL Plasma facilities are used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people in more than 100 countries.
CSL Seqirus was established in 2015 from the joining of bioCSL, CSL’s former influenza division and the legacy Novartis Influenza Vaccines business. Together the two elevated Seqirus to the second largest influenza company in the world. Seqirus today is a global vaccines leader with one of the broadest influenza vaccine portfolios, and a growing suite of vaccine technologies for COVID-19 and other respiratory pathogens.
CSL Vifor is a strong and rapidly growing presence in nephrology and is committed to launching the next generation of therapies to address the full spectrum of kidney disease, with a focus on dialysis and rare disease. This is supported by their founding heritage and expertise in iron deficiency therapy, helping to support a broad range of patients in need.
RESPONSIBILITIES:
The US Patient Advocacy and Public Affairs leads the development and execution of plans to build CSL Behring’s leadership profile and impact with key patient and other non-government stakeholders in the US, with a focus on enabling the success of our mid- to late-stage development assets and in-line business across our Therapeutic Areas of [Immunology; Hematology; Transplant; Cardiovascular and Metabolic; and Respiratory].
The role leads the analysis of stakeholder landscapes in the US to identify and assess partnership opportunities that will drive mutual priorities between CSL Behring and other stakeholders important to the success of our business.
The role will serve as the main point of contact with key non-government stakeholders in the US and be responsible together with the US PAGA and Commercial organization to coordinate and implement partnerships and collaborations. The role also will broaden, strengthen, and coordinate the company’s overall engagement with these groups to optimize partnership and funding opportunities and investments.
The role will lead the development of external public affairs content to drive advocacy priorities.
Working with the International and Global Advocacy Leads and the Coalition and Advocacy COE, the role will ensure engagement with advocacy groups in the US region adheres to levels of excellence in terms of the win-win value of the partnership and best practices in compliance.
The person in this role will be responsible for the following:
Lead analysis of stakeholder landscape in the US in key therapeutic areas relevant to CSL Behring in-line business and mid- to late-stage pipeline to identify and assess partnership opportunities.
Develop strategies to build CSL Behring profile and impact with key patient and other non-government stakeholders in the US relevant to the success of our portfolio; collaborate with US PAGA and Commercial organizations to implement partnerships and collaborations.
Working with Head, Global Advocacy and Policy, and Corporate Affairs team, coordinate process to increase internal cross-functional participation in, and transparency of, CSL Behring activities and relationships with key patient and other non-government stakeholders, to enable strategic alignment, optimization of investments, and tracking of outcomes.
Support development of public affairs content to drive CSL Behring leadership and PAGA priorities with the advocacy community in the US.
Draft internal communications to raise organizational awareness of US PAGA and its work.
QUALIFICATIONS:
Graduate/professional degree in public affairs, communications, policy, or similar disciplines preferred.
Minimum 12 years of experience in healthcare public affairs, advocacy, or comparable fields, including in global and US contexts.
Proven ability in developing and executing strategies to build company profile and impact with patient and other non-government stakeholders in the US.
Experience designing and implementing partnerships with patient groups and other non-government stakeholders in the US to drive success of in-line business and pipeline assets from development through to commercialization.
Experience generating content to support advocacy engagement across multiple channels, including campaigns, advocacy messaging, social media, and policy briefings.
Our Benefits
CSL employees that work at least 30 hours per week are eligible for benefits effective day 1. We are committed to the wellbeing of our employees and their loved ones. CSL offers resources and benefits, from health care to financial protection, so you can focus on doing work that matters. Our benefits are designed to support the needs of our employees at every stage of their life. Whether you are considering starting a family, need help paying for emergency back up care or summer camp, looking for mental health resources, planning for your financial future, or supporting your favorite charity with a matching contribution, CSL has many benefits to help achieve your goals.
Please take the time to review our benefits site to see what’s available to you as a CSL employee.
About CSL Behring
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.
We want CSL to reflect the world around us
As a global organization with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL.
Do work that matters at CSL Behring!